Yang Junzheng, Chen Chuyi, Zhang Hua, Chen Baihao, Xiao Ke, Tang Yiming, Meng Kai, Qin Ling, Chen Peng
State Key Laboratory of Traditional Chinese Medicine Syndrome, Department of Orthopaedics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China; Fifth School of Clinical Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, PR China; The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, PR China.
State Key Laboratory of Traditional Chinese Medicine Syndrome, Department of Orthopaedics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China; The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, PR China.
J Ethnopharmacol. 2025 Jan 31;340:119128. doi: 10.1016/j.jep.2024.119128. Epub 2024 Nov 29.
Pioglitazone (PIO) was an anti type 2 diabetes (T2D) agent but caused bone loss and bone marrow fat accumulation. Puerarin (PUE) was a natural component of herbal medicine extracted from Pueraria lobata (Willd.) Ohwi and reduced glycemia and improved bone mass as a supplementary drug. A combination of PIO and PUE might be good for maintaining bone mass and blood glucose.
We aimed to elucidate the potential correlation and underlying mechanisms of dietary supplement PUE in reducing side effects caused by PIO.
In vitro, alkaline phosphatase (ALP) staining, alizarin S (ARS) staining and qRT-PCR were performed to detect the osteogenesis activity in MC3T3-E1 cells. In vivo, we established the T2D model by treating C57BL6/J mice with high-fat diets and streptozotocin (STZ). Micro-CT, hematoxylin and eosin (H&E) staining and tartrate-resistant acid phosphatase (TRAcP) staining were performed to observe the difference in skeletal phenotype. Serum metabolomics and 16S rRNA amplicon sequencing were applied to analyze the potential effect of the combination of PIO and PUE.
We showed that the PUE could increase ALP activity and mineralization nodes of MC3T3-E1 with PIO. PIO could aggravate bone loss but PUE alleviated the effect caused by PIO in T2D mice. PUE promoted alpha-linolenic acid metabolism and glycerophospholipid metabolism, and affected the alpha diversity of the gut microbiome by regulating the genera of Alloprevotella, Fusobacterium, Rodentibacter, etc. Correlation analysis indicated that sphingosine-1-phosphate, nonadecylic acid, and margaric acid were associated with the effect of PUE.
Taken together, we demonstrated that PIO combined with PUE was able to lower blood sugar levels without causing bone loss. The effect of PUE mainly correlated with the genua of Alloprevotella, Fusobacterium, Rodentibacter, and Alistipes. Also, alpha-linolenic acid metabolism and glycerophospholipid metabolism were major targets of PUE.
吡格列酮(PIO)是一种抗2型糖尿病(T2D)药物,但会导致骨质流失和骨髓脂肪堆积。葛根素(PUE)是从野葛(Willd.)Ohwi中提取的草药天然成分,作为辅助药物可降低血糖并改善骨量。PIO与PUE联合使用可能有利于维持骨量和血糖水平。
我们旨在阐明膳食补充剂PUE在减轻PIO所致副作用方面的潜在关联及潜在机制。
体外实验中,进行碱性磷酸酶(ALP)染色、茜素S(ARS)染色和qRT-PCR以检测MC3T3-E1细胞中的成骨活性。体内实验中,通过用高脂饮食和链脲佐菌素(STZ)处理C57BL6/J小鼠建立T2D模型。进行Micro-CT、苏木精和伊红(H&E)染色以及抗酒石酸酸性磷酸酶(TRAcP)染色以观察骨骼表型差异。应用血清代谢组学和16S rRNA扩增子测序分析PIO与PUE联合使用的潜在作用。
我们发现PUE可增加MC3T3-E1细胞在与PIO共同作用下的ALP活性和矿化结节。PIO会加重骨质流失,但PUE可减轻T2D小鼠中PIO所致的影响。PUE促进α-亚麻酸代谢和甘油磷脂代谢,并通过调节别普雷沃氏菌属、梭杆菌属、啮齿杆菌属等菌属影响肠道微生物群的α多样性。相关性分析表明,鞘氨醇-1-磷酸、十九烷酸和壬酸与PUE的作用相关。
综上所述,我们证明PIO与PUE联合使用能够降低血糖水平且不会导致骨质流失。PUE的作用主要与别普雷沃氏菌属、梭杆菌属、啮齿杆菌属和艾利斯菌属相关。此外,α-亚麻酸代谢和甘油磷脂代谢是PUE的主要作用靶点。